J&J's Application to Extend Patent on Anti-Tuberculosis Drug Bedaquiline Rejected
The patent would have extended J&J's monopoly on the anti-TB drug in India. But with this judgment, generic manufacturers can now make their own versions at an affordable price from this year.
Source: thewire.in